Actively Recruiting
SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation for Children Undergoing Cancer Treatment
Led by Rigshospitalet, Denmark · Updated on 2026-03-19
128
Participants Needed
3
Research Sites
136 weeks
Total Duration
On this page
Sponsors
R
Rigshospitalet, Denmark
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Advances in pediatric cancer treatment have led to significant improvements in survival rates, where 5-year survival now exceeds 85%. Despite improved survival, children and adolescents who survive cancer often face significant short- and long-term psychosocial and physical late effects. Children undergoing cancer treatment often experience prolonged school absence, which disrupts their academic development and impedes critical socio-emotional growth during formative school years, with lasting consequences into adulthood. Together, these challenges underscore the need for targeted interventions that support educational continuity, promote school activity, and foster psychosocial well-being. The SchoolCare Intervention aims to reduce school absence experienced by children diagnosed with cancer during their treatment trajectory. The intervention introduces school navigation support in combination with the use of telepresence robots (TPRs) and a teleteaching program. TPRs enable the children to attend school remotely, when they are not able to attend physically. The study is designed to investigate the effectiveness of the intervention throughout a period of eight months for school-aged children (i.e., 5-17 years) who are diagnosed with cancer. The investigators hypothesize that telepresence robots will increase school attendance among children and adolescents diagnosed with cancer, representing our primary outcome (H1). Additionally, the investigators explore secondary outcomes by hypothesizing that the intervention will improve the social well-being of these children and adolescents (H2) and enhance their academic level (H3). By focusing on both school attendance and broader psychosocial and academic effects, this study will provide a comprehensive evaluation of the telepresence robot intervention and its potential to support educational continuity and well-being for children with cancer.
CONDITIONS
Official Title
SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation for Children Undergoing Cancer Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with cancer or cancer-like diseases within two months of inclusion (e.g., benign brain tumors, MDS, or LCH)
- Have undergone a stem cell transplant, or experienced cancer relapse or disease progression within two months of inclusion
- Aged 5 to 17 years
- Admitted to the pediatric oncology ward at Copenhagen University Hospital, Aarhus University Hospital, or Aalborg University Hospital
- Expected to miss more than one school day per week over an anticipated eight-month period
- Enrolled or expected to be enrolled in a school in Denmark during the eight-month intervention period
You will not qualify if you...
- Children in intervention arm B who obtain a telepresence robot outside the SchoolCare intervention
- Unable to communicate in Danish
- Physical or cognitive impairments preventing operation or meaningful engagement with the telepresence robot, as assessed by hospital personnel and the school navigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Aalborg Universitetshospital
Aalborg, Denmark
Actively Recruiting
2
Aarhus Universitetshospital
Aarhus, Denmark
Actively Recruiting
3
Rigshospitalet
Copenhagen, Denmark
Actively Recruiting
Research Team
H
Hanne B Larsen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here